<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
under Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 000-26872
GELTEX PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
153 SECOND AVENUE, WALTHAM, MASSACHUSETTS 02451
(781) 290-5888
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
COMMON STOCK, $.01 PAR VALUE PER SHARE
JUNIOR PARTICIPATING PREFERRED STOCK PURCHASE RIGHTS
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of securities for which a duty to file reports
under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(ii) |_|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(2)(i) |_|
Rule 12g-4(a)(2)(i) |_| Rule 12h-3(b)(2)(ii) |_|
Rule 12g-4(a)(2)(ii) |_| Rule 15d-6 |_|
Rule 12h-3(b)(1)(i) |X|
Approximate number of holders of record as of the certification or
notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934,
GELTEX PHARMACEUTICALS, INC. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
Date: December 14, 2000 GELTEX PHARMACEUTICALS, INC.
By: /s/ Peter Wirth
-----------------------------------
Peter Wirth
President
